The effectiveness of intrathecal treatment varies depending on the type of cancer and its stage. However, numerous studies have demonstrated significant benefits in terms of controlling CNS malignancies and improving patient outcomes. For example, intrathecal methotrexate has been shown to be highly effective in preventing and treating CNS involvement in certain leukemias and lymphomas.
